![Ronald Renaud](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Renaud
Président chez
UPSTREAM BIO, INC.
Fortune : 586 648 $ au 31/08/2026
Profil
Ronald C.
Renaud is President, Chief Executive Officer & Director at Kailera Therapeutics, Inc. since 2024.
He is Chairman at Upstream Bio, Inc. since 2021.
He serves as Director at Jnana Therapeutics, Inc., Trustee at St. Anselm College, Member of the Overseers Board at Newton-Wellesley Hospital Corp., and Senior Advisor at Bain Capital Life Sciences LP since 2023.
Former positions include President, CEO, CFO & Director at Idenix Pharmaceuticals LLC from 2010 to 2014; Chairman & Chief Executive Officer at Translate Bio, Inc. in 2021; President, Chief Executive Officer & Director at Cerevel Therapeutics Holdings, Inc. from 2023 to 2024; Chairman at Ikena Oncology, Inc. from 2018 to 2022; Managing Director at Bear, Stearns & Co., Inc.; Managing Director at Charles Schwab & Co., Inc. from 2001 to 2004; Independent Class Director at PTC Therapeutics, Inc. from 2015 to 2017; Independent Director at Akebia Therapeutics, Inc. from 2014 to 2018; Board of Directors at American Liver Foundation of Northern California from 2012 to 2014; Managing Director at Soundview Capital Management Corp.
from 2001 to 2004; Independent Director at Vertero Therapeutics, Inc. starting 2017; Independent Director at Chimerix, Inc. from 2014 to 2021; Chief Financial Officer, Treasurer & Senior VP at Keryx Biopharmaceuticals, Inc. from 2006 to 2007; Analyst at JPMorgan Securities LLC in 2006; Research Analyst at Schwab SoundView Capital Markets from 2003 to 2004; Chairperson of the Board at Atara Biotherapeutics, Inc. from 2020 to 2022; Partner at Bain Capital Holdings LP from 2022 to 2023; and Advisor at Atlas Venture Advisors, Inc.Education includes an undergraduate degree from St. Anselm College conferred in 1990 and an MBA from USC Marshall School of Business conferred in 1999.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,03 % | 09/06/2026 | 38 094 ( 0,03 % ) | 586 648 $ | 31/08/2026 |
UPSTREAM BIO, INC. -.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Ronald Renaud
| Sociétés | Poste | Début |
|---|---|---|
| UPSTREAM BIO, INC. | Président | 01/11/2021 |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Consultant / Advisor | 01/06/2023 |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Directeur/Membre du Conseil | - |
Newton-Wellesley Hospital Corp.
 Newton-Wellesley Hospital Corp. Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | - |
St. Anselm College
 St. Anselm College Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Anciens postes connus de Ronald Renaud
| Sociétés | Poste | Fin |
|---|---|---|
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Président | 16/12/2025 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Directeur Général | 01/08/2024 |
Bain Capital Holdings LP
 Bain Capital Holdings LP Investment ManagersFinance Provides alternative asset management services | Private Equity Investor | 01/06/2023 |
| ATARA BIOTHERAPEUTICS, INC. | Président | 19/12/2022 |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Ronald Renaud
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Bear, Stearns & Co., Inc.
 Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage Services | Finance |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Charles Schwab & Co., Inc.
 Charles Schwab & Co., Inc. Investment Banks/BrokersFinance Provides financial instruments, securities brokerage and investment advisory services | Finance |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Schwab SoundView Capital Markets
 Schwab SoundView Capital Markets Investment Banks/BrokersFinance Provides financial and brokerage services | Finance |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
St. Anselm College
St. Anselm College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newton-Wellesley Hospital Corp.
Newton-Wellesley Hospital Corp. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
American Liver Foundation of Northern California | |
USC Marshall School of Business
 USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Soundview Capital Management Corp.
 Soundview Capital Management Corp. Investment ManagersFinance Provides investment advice | Finance |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Health Technology |
Ikena Oncology, Inc.
 Ikena Oncology, Inc. BiotechnologyHealth Technology Develops metabolic enzymes based immunotherapy for oncology applications | Health Technology |
Bain Capital Holdings LP
Bain Capital Holdings LP Investment ManagersFinance Provides alternative asset management services | Finance |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
